Skip to main content

GeneDx Holdings Corp.

corporate_fare Company Profile

GeneDx Holdings Corp.

WGS·NASDAQ·Industrial Applications And Services·CIK 0001818331

GeneDx Holdings Corp. provides genomic testing services. The company offers ExomeDx™ and GenomeDx™ tests, which are ranked #1 by expert geneticists and have received FDA Breakthrough Device Designation. These tests enable clinicians to provide precise, fast, and actionable diagnoses. GeneDx Holdings combines clinical expertise, advanced technology, and its proprietary GeneDx Infinity™ dataset to power these tests. The GeneDx Infinity™ dataset also supports discovery for biopharma and aims to drive the future of precision genetic medicine. GeneDx was founded in 2000 by scientists from the National Institutes of Health with the goal of making genetic testing accessible for patients with rare diseases. The company became a leader in genomics, establishing methods for providing genomic information at scale and pioneering exome and genome sequencing for rare and ultra-rare genetic pediatric disorders. Over 25 years, GeneDx has built one of the world's largest rare disease datasets, GeneDx Infinity™. GeneDx Holdings acquired GeneDx, LLC on April 29, 2022, and Fabric Genomics, Inc. on May 5, 2025. The company's Class A common stock and public warrants are listed on the Nasdaq Global Select Market under the symbols "WGS" and "WGSWW," respectively.

GeneDx Holdings Corp. (NASDAQ:WGS) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 34 items for WGS at importance 7 or higher on its 1–10 market-impact scale.

Recent high-impact activity:

  • Directors & 10% Owners Buy $46.8M in Shares After Negative Q1 Report
  • Director/10% Owner Casdin Partners Acquires $33.37M Notional Exposure in GeneDx Swaps Post-Earnings
  • GeneDx Slashes 2026 Revenue Forecast by Over 10%, Shares Plunge 41% Premarket
  • GeneDx Projects $5M Adjusted Loss for Q2
  • GeneDx Slashes FY26 Revenue Outlook by Over 10% After Q1 Misses Estimates

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$427.54M
Net Income
-$21.02M
Diluted EPS
-$0.73
Op. Cash Flow
$33.28M
Free Cash Flow
$14.26M
Gross Profit
$298.17M
Operating Income
-$13.08M
Cash & Equivalents
$105M
Total Debt
$52.72M
Debt / Equity
0.17×
Net Margin
-4.9%
Shares Outstanding
29.25M sh
Source: 10-K · filed 2026-02-23 · accession 0001818331-26-000015
$46.35 +1.96% today
52-week range · as of 2026-11-18 $32.21 – $170.87
Market cap
$1.36B
Volume
912.6K (0.8× avg)
3-mo avg 1.1M
Live data · 2026-11-22 12:54 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed WGS - Filings & News (Page 2)

WGS
May 11, 2026, 9:20 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
9
Price at Filing: $39.42
Real-time Price: $46.35 info
Change: +$6.93 (+18%) info
Market Cap: $1.363B info
WGS
May 11, 2026, 8:43 PM EDT
Filing Type: 4
Importance Score:
8
Price at Filing: $39.42
Real-time Price: $46.35 info
Change: +$6.93 (+18%) info
Market Cap: $1.363B info
WGS
May 05, 2026, 6:40 AM EDT
Source: Dow Jones Newswires
Importance Score:
9
Price at Filing: $39.80
Real-time Price: $46.35 info
Change: +$6.55 (+16%) info
Market Cap: $1.363B info
WGS
May 04, 2026, 4:43 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $38.00
Real-time Price: $46.35 info
Change: +$8.35 (+22%) info
Market Cap: $1.363B info
WGS
May 04, 2026, 4:19 PM EDT
Source: Reuters
Importance Score:
9
Price at Filing: $46.06
Real-time Price: $46.35 info
Change: +$0.2927 (+0.64%) info
Market Cap: $1.363B info
WGS
May 04, 2026, 4:15 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $36.87
Real-time Price: $46.35 info
Change: +$9.48 (+26%) info
Market Cap: $1.363B info
WGS
May 04, 2026, 4:09 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $46.12
Real-time Price: $46.35 info
Change: +$0.230 (+0.50%) info
Market Cap: $1.363B info
WGS
Mar 05, 2026, 7:19 PM EST
Filing Type: 4
Importance Score:
7
Price at Filing: $82.50
Real-time Price: $46.35 info
Change: -$36.15 (-44%) info
Market Cap: $1.363B info
WGS
Mar 02, 2026, 7:13 AM EST
Source: Unknown
Importance Score:
7
Price at Filing: $79.41
Real-time Price: $46.35 info
Change: -$33.06 (-42%) info
Market Cap: $1.363B info
WGS
Mar 02, 2026, 7:02 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $79.41
Real-time Price: $46.35 info
Change: -$33.06 (-42%) info
Market Cap: $1.363B info
WGS
Feb 23, 2026, 8:21 AM EST
Filing Type: 10-K
Importance Score:
8
Price at Filing: $84.26
Real-time Price: $46.35 info
Change: -$37.91 (-45%) info
Market Cap: $1.363B info
WGS
Feb 23, 2026, 8:16 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $84.26
Real-time Price: $46.35 info
Change: -$37.91 (-45%) info
Market Cap: $1.363B info
WGS
Jan 29, 2026, 7:25 PM EST
Filing Type: 144
Importance Score:
7
Price at Filing: $98.17
Real-time Price: $46.35 info
Change: -$51.82 (-53%) info
Market Cap: $1.363B info
WGS
Jan 12, 2026, 5:10 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $116.86
Real-time Price: $46.35 info
Change: -$70.51 (-60%) info
Market Cap: $1.363B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets